Haemonetics - 29 Year Stock Price History | HAE

Historical daily share price chart and data for Haemonetics since 1991 adjusted for splits. The latest closing stock price for Haemonetics as of October 26, 2020 is 106.50.
  • The all-time high Haemonetics stock closing price was 138.52 on August 16, 2019.
  • The Haemonetics 52-week high stock price is 130.75, which is 22.8% above the current share price.
  • The Haemonetics 52-week low stock price is 63.41, which is 40.5% below the current share price.
  • The average Haemonetics stock price for the last 52 weeks is 102.18.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Haemonetics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 98.6227 115.2700 121.8200 74.3400 106.5000 -7.31%
2019 109.5747 97.3000 138.5200 81.7400 114.9000 14.84%
2018 90.5582 63.1000 116.6300 60.7200 100.0500 72.26%
2017 43.6000 39.6000 58.9900 36.9000 58.0800 44.48%
2016 33.6385 31.2500 41.0400 26.1300 40.2000 24.69%
2015 38.4527 36.9200 45.3800 30.8500 32.2400 -13.84%
2014 35.9682 41.2800 43.3700 30.3600 37.4200 -11.18%
2013 41.3454 42.1300 45.8100 37.7500 42.1300 3.16%
2012 36.4214 31.3900 41.3800 30.9250 40.8400 33.42%
2011 31.0832 30.1400 35.1000 27.5050 30.6100 -3.10%
2010 28.1781 27.7150 32.1900 25.6200 31.5900 14.56%
2009 27.4175 28.0050 32.3250 24.4250 27.5750 -2.39%
2008 28.8424 30.9200 32.7100 24.7950 28.2500 -10.35%
2007 25.2441 22.6900 31.5100 21.7500 31.5100 39.98%
2006 24.0376 24.4000 27.4500 20.5450 22.5100 -7.86%
2005 21.6156 18.4000 26.3950 17.0800 24.4300 34.94%
2004 15.1271 11.9700 18.4950 11.8700 18.1050 51.57%
2003 10.5794 11.0000 12.2350 8.2400 11.9450 11.32%
2002 13.6927 16.8400 17.1750 9.3500 10.7300 -36.73%
2001 16.3680 14.8450 20.8500 13.7000 16.9600 9.84%
2000 11.8993 11.7800 15.4400 9.9400 15.4400 29.69%
1999 9.4026 11.3450 12.0300 6.9050 11.9050 4.66%
1998 8.7493 7.1550 11.4050 6.7500 11.3750 62.50%
1997 8.5821 9.3750 10.3450 6.9050 7.0000 -25.85%
1996 9.1787 8.8750 10.5000 8.1875 9.4400 6.37%
1995 9.0690 8.6900 11.5000 6.5650 8.8750 2.13%
1994 9.6435 13.5000 13.6900 7.2500 8.6900 -37.37%
1993 11.7904 12.4700 14.1250 8.3750 13.8750 5.96%
1992 8.4564 9.0950 13.0950 6.1875 13.0950 38.28%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $5.422B $0.988B
Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through proper blood management, their portfolio of products and services helps to prevent a transfusion for the patient who doesn't need one and provides the right blood product, at the right time, in the right dose to the right patient who does.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $190.845B 34.22
Medtronic (MDT) Ireland $149.772B 28.21
Stryker (SYK) United States $83.174B 32.25
Boston Scientific (BSX) United States $53.178B 30.72
Lonza Group Ag (LZAGY) Switzerland $47.347B 0.00
Baxter (BAX) United States $41.050B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $30.025B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.548B 24.52
Terumo (TRUMY) Japan $28.364B 36.26
ResMed (RMD) United States $26.523B 38.45
Sunny Optical Technology (SNPTF) China $17.297B 0.00
Bio-Rad Laboratories (BIO) United States $17.264B 78.08
Smith & Nephew SNATS (SNN) United Kingdom $16.848B 0.00
Insulet (PODD) United States $16.373B 692.75
DiaSorin S.p.A (DSRLF) Italy $12.588B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
Quidel (QDEL) United States $10.412B 55.16
GN STORE NORD (GNNDY) Denmark $9.996B 50.95
William Demant Holdings (WILYY) Denmark $8.193B 0.00
Canopy Growth (CGC) Canada $7.335B 0.00
Perrigo (PRGO) Ireland $6.226B 10.68
Hill-Rom Holdings (HRC) United States $6.153B 15.27
Envista Holdings (NVST) United States $4.406B 30.04
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.095B 0.00
ICU Medical (ICUI) United States $4.037B 30.80
Abcam (ABCZY) $3.853B 0.00
Neogen (NEOG) United States $3.834B 62.86
National Vision Holdings (EYE) United States $3.469B 539.13
TG Therapeutics (TGTX) United States $3.420B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $2.949B 0.00
NuVasive (NUVA) United States $2.684B 37.40
Agios Pharmaceuticals (AGIO) United States $2.629B 0.00
DFB Healthcare Acquisitions (AHCO) United States $2.406B 0.00
AtriCure (ATRC) United States $1.706B 0.00
Owens & Minor (OMI) United States $1.627B 36.44
Cardiovascular Systems (CSII) United States $1.568B 0.00
NanoString Technologies (NSTG) United States $1.372B 0.00
InMode (INMD) Israel $1.327B 33.46
Aphria (APHA) Canada $1.314B 0.00
MacroGenics (MGNX) United States $1.195B 0.00
Quanterix (QTRX) United States $1.154B 0.00
OraSure Technologies (OSUR) United States $1.067B 0.00
Cerus (CERS) United States $1.054B 0.00
BioLife Solutions (BLFS) United States $0.929B 483.67
PetIQ (PETQ) United States $0.871B 24.98
Lantheus Holdings (LNTH) United States $0.864B 11.97
Vapotherm (VAPO) United States $0.814B 0.00
Meridian Bioscience (VIVO) United States $0.786B 18.15
Phibro Animal Health (PAHC) United States $0.739B 16.93
LeMaitre Vascular (LMAT) United States $0.664B 40.52
Eagle Pharmaceuticals (EGRX) United States $0.637B 90.04
Omeros (OMER) United States $0.581B 0.00
Surmodics (SRDX) United States $0.557B 61.08
Varex Imaging (VREX) United States $0.555B 24.05
Aurora Cannabis (ACB) Canada $0.540B 0.00
Zynex (ZYXI) United States $0.502B 43.85
Surface Oncology (SURF) United States $0.382B 0.00
Viemed Healthcare (VMD) United States $0.372B 13.22
HEXO (HEXO) $0.372B 0.00
Cytosorbents (CTSO) United States $0.358B 0.00
Utah Medical Products (UTMD) United States $0.309B 26.54
SEMPERIT AG HLD (SEIGY) Austria $0.257B 0.00
Organigram Holdings (OGI) Canada $0.245B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.216B 0.00
Bovie Medical (APYX) United States $0.214B 0.00
Wound Management Technologies (SMTI) United States $0.191B 0.00
Exagen (XGN) United States $0.185B 0.00
Chimerix (CMRX) United States $0.175B 0.00
Female Health (VERU) United States $0.172B 0.00
Fonar (FONR) United States $0.138B 18.29
Liberty Health Sciences (LHSIF) United States $0.130B 0.00
Evolus (EOLS) United States $0.118B 0.00
Chembio Diagnostics (CEMI) United States $0.099B 0.00
Capricor Therapeutics (CAPR) United States $0.088B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.076B 0.00
United-Guardian (UG) United States $0.068B 15.31
Rockwell Medical (RMTI) United States $0.067B 0.00
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.065B 12.23
Nephros (NEPH) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.060B 0.00
MTech Acquisition (KERN) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.024B 0.00
FSD PHARMA INC (HUGE) Canada $0.024B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Akers Biosciences Inc (AKER) United States $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.006B 0.00